Sirolimus-Eluting Versus Paclitaxel-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease
- 18 January 2006
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (3) , 507-514
- https://doi.org/10.1016/j.jacc.2005.09.040
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registryJournal of the American College of Cardiology, 2005
- Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery DiseaseCirculation, 2005
- Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left MainCirculation, 2005
- Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: Comparison with bare metal stent implantationJournal of the American College of Cardiology, 2005
- Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent RestenosisJAMA, 2005
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyPublished by Elsevier ,2004
- Simplified scoring system for predicting mortality after percutaneous coronary interventionJournal of the American College of Cardiology, 2003
- Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patientsEuropean Journal of Cardio-Thoracic Surgery, 1999